Cargando…

Are we progressing in prostate cancer management?

Detalles Bibliográficos
Autores principales:	Patel, Hiten RH., Patel, Reena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Second Military Medical University 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099682/ https://www.ncbi.nlm.nih.gov/pubmed/33996484 http://dx.doi.org/10.1016/j.ajur.2020.09.001

Ejemplares similares

New Year’s greeting and overview of World Journal of Clinical Oncology in 2021
por: Gong, Ze-Mao, et al.
Publicado: (2021)

We all progress through progress towards gender equality
por: Ovseiko, Pavel V., et al.
Publicado: (2020)

We should learn from the Asia–Pacific responses to COVID-19
por: Patel, Jay, et al.
Publicado: (2020)

Emerging role of artificial intelligence in medical sciences—Are we ready!
por: Garg, Rakesh, et al.
Publicado: (2021)

5-α reductase inhibitors and prostate cancer prevention: where do we turn now?
por: Hamilton, Robert J, et al.
Publicado: (2011)

Integrating phosphoproteomics into the clinical management of prostate cancer
por: Cheng, Larry C., et al.
Publicado: (2017)

Allied health growth: what we do not measure we cannot manage
por: Solomon, Daniela, et al.
Publicado: (2015)

The need for a personalized approach for prostate cancer management
por: Sedelaar, JP Michiel, et al.
Publicado: (2015)

Risk stratification tools in prostate cancer, where do we stand?
por: Clinckaert, Andries, et al.
Publicado: (2021)

Recent progress in sepsis epidemiology – have we learned enough?
por: Gerlach, Herwig, et al.
Publicado: (2003)

Massive bleeding in polytrauma: how can we make progress?
por: Vincent, Jean-Louis, et al.
Publicado: (2011)

Persistent postsurgical pain—How can we make progress?
por: Kehlet, Henrik
Publicado: (2019)

Current and Emerging Treatment Options for Patients with Metastatic EGFR-Mutated Non-small Cell Lung Cancer After Progression on Osimertinib and Platinum-Based Chemotherapy: A Podcast Discussion
por: Patel, Sandip, et al.
Publicado: (2023)

Transperitoneal laparoscopic adrenalectomy for metachronous contralateral adrenal metastasis from renal cell carcinoma: a case report
por: Zacharakis, Evangelos, et al.
Publicado: (2008)

Commentary: Retinoblastoma management—Where are we and where do we go from here?
por: Shanmugam, P Mahesh
Publicado: (2020)

Artificial intelligence, robotics and eye surgery: are we overfitted?
por: Urias, Müller G., et al.
Publicado: (2019)

An Evaluation Framework for Defining the Contributions of Telestration in Surgical Telementoring
por: Budrionis, Andrius, et al.
Publicado: (2013)

Vaccine financing in Nigeria: are we making progress towards self-financing/sustenance?
por: Faniyan, Olumide, et al.
Publicado: (2017)

Breast cancer research: where we are and where we should go
por: Liu, Edison T
Publicado: (2000)

Do we really need standards in digital image management?
por: Ho, ELM
Publicado: (2008)

How Should We Manage Iatrogenic Perforation Caused by Colonoscopy?
por: Kim, Eun Sun
Publicado: (2016)

Elastic tubes: the ideal equipment for telehealth exercise medicine in the management of prostate cancer?
por: Mavropalias, Georgios
Publicado: (2022)

Looking back and moving forward: can we accelerate progress on adolescent pregnancy in the Americas?
por: Caffe, Sonja, et al.
Publicado: (2017)

Are we ready to include invasive cribriform and intraductal carcinoma into the prostate cancer grade grouping system?
por: Xiao, Guang-Qian, et al.
Publicado: (2020)

The Management of Metastatic Castrate-Sensitive Prostate Cancer: From Guidelines to Real-World Practice
por: Gebrael, Georges, et al.
Publicado: (2023)

Beyond killing: Can we find new ways to manage infection?
por: Vale, Pedro F., et al.
Publicado: (2016)

Mitochondrial oxidative stress drives tumor progression and metastasis: should we use antioxidants as a key component of cancer treatment and prevention?
por: Sotgia, Federica, et al.
Publicado: (2011)

PREDICT Prostate, a useful tool in men with low- and intermediate-risk prostate cancer who are hesitant between conservative management and active treatment
por: Devos, Gaëtan, et al.
Publicado: (2020)

Identification and management of adults with asthma prone to exacerbations: can we do better?
por: Thomson, Neil C, et al.
Publicado: (2008)

It is time to change the way we manage mild asthma: an update in GINA 2019
por: Muneswarao, Jaya, et al.
Publicado: (2019)

Will we cure cancer by sequencing thousands of genomes?
por: Nicholson, Joshua M
Publicado: (2013)

Surgical Management of Synucleinopathies
por: Sriram, Sai, et al.
Publicado: (2022)

Commentary: Pleurography: We can, but should we?
por: Benz, Cecilia, et al.
Publicado: (2021)

Diet and COPD: Are we what we eat?
por: Sin, Don D.
Publicado: (2019)

Extended lymph node dissection for intermediate and high-risk prostate cancer: do we have all the evidence?
por: Ghazi, Ahmed
Publicado: (2015)

Acute stroke: we have the treatments and we have the evidence – we need to use them
por: Quinn, Terence J, et al.
Publicado: (2007)

We bawl so we are heard: the stories we must tell about obstetric racism
por: Maurice, Rochelle
Publicado: (2023)

Commentary: Managing catastrophic antiphospholipid syndrome—do we have a way out?
por: Hirji, Sameer A., et al.
Publicado: (2021)

Blood management in intensive care medicine: CRIT and ABC – what can we learn?
por: Spahn, Donat R, et al.
Publicado: (2004)

Recently published papers: We are what we eat?
por: Forni, LG
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_hp9p2rp5du96c3kgouql825l8l